MPI-0479605
99%
- Product Code: 101549
Alias:
N6-cyclohexyl-N2-(2-methyl-4-morpholine phenyl)-9H-purine-2,6-diamine
CAS:
1246529-32-7
| Molecular Weight: | 407.51 g./mol | Molecular Formula: | C₂₂H₂₉N₇O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD28099811 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
MPI-0479605 is primarily investigated for its potential therapeutic applications in the field of oncology. It functions as a selective inhibitor targeting specific kinases involved in cancer cell proliferation and survival. Research indicates its efficacy in disrupting signaling pathways that contribute to tumor growth, making it a promising candidate for treating various types of cancers. Preclinical studies have shown that MPI-0479605 can induce apoptosis in cancer cells while sparing normal cells, highlighting its potential for targeted cancer therapy. Additionally, it is being explored in combination with other anticancer agents to enhance treatment outcomes and overcome drug resistance. Ongoing clinical trials aim to evaluate its safety, tolerability, and efficacy in human patients, paving the way for its potential use in personalized medicine approaches.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White To Light-Gray Powder Or Crystals |
| Purity (%) | 98.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | $267.03 |
+
-
|
MPI-0479605
MPI-0479605 is primarily investigated for its potential therapeutic applications in the field of oncology. It functions as a selective inhibitor targeting specific kinases involved in cancer cell proliferation and survival. Research indicates its efficacy in disrupting signaling pathways that contribute to tumor growth, making it a promising candidate for treating various types of cancers. Preclinical studies have shown that MPI-0479605 can induce apoptosis in cancer cells while sparing normal cells, highlighting its potential for targeted cancer therapy. Additionally, it is being explored in combination with other anticancer agents to enhance treatment outcomes and overcome drug resistance. Ongoing clinical trials aim to evaluate its safety, tolerability, and efficacy in human patients, paving the way for its potential use in personalized medicine approaches.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :